A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 60
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : MBs
Long Form : medulloblastomas
No. Year Title Co-occurring Abbreviation
2019 Transcriptional repressor REST drives lineage stage-specific chromatin compaction at Ptch1 and increases AKT activation in a mouse model of medulloblastoma. CGNPs, REST, RESTTG, SHH
2018 BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation. ADGRs, BAI1
2018 Increased cytomegalovirus replication by 5-Azacytidine and viral-induced cytoplasmic expression of DNMT‑1 in medulloblastoma and endothelial cells. 5-aza, HCMV, HUVECs
2018 Signaling pathway deregulation and molecular alterations across pediatric medulloblastomas. ---
2018 The association of NF2 (neurofibromin 2) gene polymorphism and the risk of medulloblastomas. WB
2017 Cerebellopontine angle medulloblastoma with extensive nodularity in a child: case report and review of the literature. CPA
2017 Spatial heterogeneity in medulloblastoma. HGGs, RCC
2017 The ubiquitin-proteasome system and chromosome 17 in cerebellar granule cells and medulloblastoma subgroups. ---
2016 The Interaction of Myc with Miz1 Defines Medulloblastoma Subgroup Identity. GNPs, Myc, SHH
10  2016 WIP1 modulates responsiveness to Sonic Hedgehog signaling in neuronal precursor cells and medulloblastoma. EGL, ND2, SHH
11  2015 Cytogenetic landscape of paired neurospheres and traditional monolayer cultures in pediatric malignant brain tumors. CSCs, HGGs, NSTCs
12  2015 Paired box gene 8 (PAX8) expression is associated with sonic hedgehog (SHH)/wingless int (WNT) subtypes, desmoplastic histology and patient survival in human medulloblastomas. CNS, PAX8, SHH, siRNA, WNT
13  2015 Wnt activation affects proliferation, invasiveness and radiosensitivity in medulloblastoma. LI
14  2014 Diagnostic application of high resolution single nucleotide polymorphism array analysis for children with brain tumors. DNT, GG, LGGs, PA, SNP
15  2014 Inhibitory potential of postnatal treatment with cyclopamine, a hedgehog signaling inhibitor, on medulloblastoma development in Ptch1 heterozygous mice. EGL, PND, Ptch1, Shh
16  2014 Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms. CNS, miRNA
17  2013 CARP-1 functional mimetics: a novel class of small molecule inhibitors of medulloblastoma cell growth. APC/C, CFMs, MMP, SAPK
18  2013 The role of microRNAs in medulloblastoma. miRNAs
19  2012 Expression profile of frizzled receptors in human medulloblastomas. FZD
20  2012 Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study. CSRT, MC, VCR
21  2012 WIP1 enhances tumor formation in a sonic hedgehog-dependent model of medulloblastoma. SHH/PTC, Wip1
22  2011 All-trans retinoic acid enhances bystander effect of suicide-gene therapy against medulloblastomas. ATRA, GJIC, HSV-TK, NSC
23  2011 Bystander effect in suicide gene therapy using immortalized neural stem cells transduced with herpes simplex virus thymidine kinase gene on medulloblastoma regression. Cx43, GCV, HSV-TK, NSCs
24  2011 Embryonal central nervous system neoplasms arising in infants and young children: a pediatric brain tumor consortium study. OS, PFS
25  2011 Shared molecular targets in pediatric gliomas and ependymomas. G-CSFR, PCNA, PDGFRalpha, PNET, SPARC, SUFU
26  2010 Evaluation of retinoic acid therapy for OTX2-positive medulloblastomas. FGF, RAs
27  2010 Expression of epidermal growth factor receptor and HER-2 in pediatric embryonal brain tumors. EGFR, PNETs
28  2010 The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis. CAs, PNETs
29  2009 c-Met activation in medulloblastoma induces tissue factor expression and activity: effects on cell migration. FVII, HGF, TF
30  2009 The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. GNPs, SHH
31  2008 Do medulloblastoma tumors meet the Food and Drug Administration criteria for anti-erbB2 therapy with trastuzumab? ---
32  2008 Intravascular thrombosis in central nervous system malignancies: a potential role in astrocytoma progression to glioblastoma. AA, CNS, GBM, METs, PCNSLs, WHO
33  2007 All-trans-retinoic acid induces cell growth arrest in a human medulloblastoma cell line. ATRA, RA
34  2007 Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas. ---
35  2007 [Different hypermethylation status of RASSF1A in medulloblastoma and supratentorial primitive neuroectodermal tumor]. MSP, PNETs, SPNETs
36  2006 Medulloblastomas: new directions in risk stratification. ---
37  2006 XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice. Ptc
38  2005 Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor. sPNETs
39  2005 Identification of differentially expressed genes in human pineal parenchymal tumors by microarray analysis. PPTs
40  2005 Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells. GCPs, IGF-II, Shh
41  2005 Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors. sPNETs
42  2005 Subtype-specific expression and genetic alterations of the chemokinereceptor gene CXCR4 in medulloblastomas. ---
43  2004 Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. ---
44  2004 Expression of MATH1, a marker of cerebellar granule cell progenitors, identifies different medulloblastoma sub-types. CGCs, EGL
45  2004 Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT signaling. TCF
46  2004 Karyotypic evolution pathways in medulloblastoma/primitive neuroectodermal tumor determined with a combination of spectral karyotyping, G-banding, and fluorescence in situ hybridization. FISH, PNETs, SKY
47  2004 No evidence for mutations or altered expression of the Suppressor of Fused gene (SUFU) in primitive neuroectodermal tumours. APC, PNETs, RT-PCR, Shh, SNPs, SSCP, SUFU
48  2003 A comparative study of classical vs. desmoplastic medulloblastomas. AI, MIB-1 LI
49  2003 Epigenetic silencing of the HIC-1 gene in human medulloblastomas. HIC-1
50  2003 Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas. ---
51  2002 Human medulloblastomas lack point mutations and homozygous deletions of the hSNF5/INI1 tumour suppressor gene. PNETs, SPNETs
52  2001 Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs. BAC, RLGS, stPNETs
53  2000 "Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group Study. LC MBs, POG
54  2000 Expression of the neurotrophin receptor p75NTR in medulloblastomas is correlated with distinct histological and clinical features: evidence for a medulloblastoma subtype derived from the external granule cell layer. CMB, EGL, PNET
55  1999 Analysis of the Max-binding protein MNT in human medulloblastomas. SSCP
56  1999 Medulloblastoma with extensive nodularity: a variant with favorable prognosis. ---
57  1997 Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin. GMs
58  1997 Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. ---
59  1992 Medulloblastomas and related primitive neuroectodermal brain tumors of childhood recapitulate molecular milestones in the maturation of neuroblasts. CNS, PNETs
60  1991 "Desmoplastic" versus "classic" medulloblastoma: comparison of DNA content, histopathology and differentiation. ---